Aqemia is a deep-tech start-up in drug discovery.
Aqemia has raised €233M across 6 funding rounds from 7 investors, most recently a Grant round in Apr 2025. Based in Paris, France; founded 2019; active in Healthtech. Data as of 8 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2025-04-01 | Grant | €6.9M | — | View deal → |
| 2024-12-10 | Other | €36M | Cathay Innovation | View deal → |
| 2024-01-30 | Series A | €30M | Bpifrance Large Venture,Elaia,Eurazeo,Wendel Growth | View deal → |
| 2023-12-05 | Other | €129M | Sanofi | View deal → |
| 2022-10-19 | Series A | €30M | Bpifrance's Large Venture fund,Eurazeo | View deal → |
| 2019-10-01 | Pre-Seed | €1.0M | Elaia | View deal → |
